Northrop Grumman Corporation Common Stock (NOC)
Healthcare › Search, Detection, Navigation, Guidance, Aeronautical Sys
Price History
Feb 9, 2026 — Aug 13, 2026Investment Snapshot
- Trading 72% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 6/9 — moderate financial health
- Strong ROE of 23.7% with 10.2% net margin
Northrop Grumman Corporation Common Stock (NOC) is a Healthcare company operating in Search, Detection, Navigation, Guidance, Aeronautical Sys, listed on the NYSE , with a market capitalisation of $70.9 billion . Key value metrics: P/E ratio 16.7, P/B ratio 3.97, Piotroski F-Score 6 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Northrop Grumman Corporation Common Stock — Fundamental Analysis Summary
Northrop Grumman Corporation Common Stock (NOC) is currently trading 72% above its Graham Number of $290.86, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries a reasonable trailing P/E ratio of 16.7x.
On financial health, NOC shows a moderate Piotroski F-Score of 6/9, and strong return on equity of 23.7% (sector average: -20.1%), and manageable leverage with a debt-to-equity ratio of 0.88.
StockPik's composite Value Score for NOC is 67/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
NOC shows revenue growing at 2% year-over-year, with earnings growing at 0%.
NOC pays a modest dividend yield of 1.9%.